Vivicells International Stock Fundamentals
| VCII Stock | USD 0.0001 0.00 0.00% |
ViviCells International fundamentals help investors to digest information that contributes to ViviCells International's financial success or failures. It also enables traders to predict the movement of ViviCells Stock. The fundamental analysis module provides a way to measure ViviCells International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ViviCells International stock.
As of now, ViviCells International's Income Before Tax is increasing as compared to previous years. The ViviCells International's current Income Tax Expense is estimated to increase to about 278.9 K, while Selling General Administrative is projected to decrease to under 820 K. ViviCells | Select Account or Indicator |
ViviCells International Company Profit Margin Analysis
ViviCells International's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current ViviCells International Profit Margin | (0.09) % |
Most of ViviCells International's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ViviCells International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ViviCells Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for ViviCells International is extremely important. It helps to project a fair market value of ViviCells Stock properly, considering its historical fundamentals such as Profit Margin. Since ViviCells International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ViviCells International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ViviCells International's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, ViviCells International has a Profit Margin of -0.0857%. This is 100.96% lower than that of the Independent Power and Renewable Electricity Producers sector and significantly lower than that of the Utilities industry. The profit margin for all United States stocks is 93.25% lower than that of the firm.
ViviCells International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ViviCells International's current stock value. Our valuation model uses many indicators to compare ViviCells International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViviCells International competition to find correlations between indicators driving ViviCells International's intrinsic value. More Info.ViviCells International is rated first in profit margin category among its peers. It is rated first in operating margin category among its peers . As of now, ViviCells International's Net Loss is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ViviCells International's earnings, one of the primary drivers of an investment's value.ViviCells Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ViviCells International's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ViviCells International could also be used in its relative valuation, which is a method of valuing ViviCells International by comparing valuation metrics of similar companies.ViviCells International is currently under evaluation in profit margin category among its peers.
ViviCells Fundamentals
| Profit Margin | (0.09) % | ||||
| Operating Margin | 0.46 % | ||||
| Current Valuation | 46.77 K | ||||
| Shares Outstanding | 233.88 M | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 3.77 M | ||||
| Gross Profit | 1.71 M | ||||
| EBITDA | 294.18 K | ||||
| Net Income | (14.44 K) | ||||
| Cash And Equivalents | 10.26 K | ||||
| Total Debt | 22.31 K | ||||
| Debt To Equity | 1.07 % | ||||
| Current Ratio | 5.01 X | ||||
| Cash Flow From Operations | (1.21 M) | ||||
| Beta | -2.7 | ||||
| Market Capitalization | 46.78 K | ||||
| Total Asset | 5.32 M | ||||
| Working Capital | 2.48 M | ||||
| Current Asset | 6.6 M | ||||
| Current Liabilities | 4.12 M | ||||
| Net Asset | 5.32 M |
About ViviCells International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ViviCells International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViviCells International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViviCells International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 4.3 M | 3.3 M | |
| Cost Of Revenue | 2.4 M | 2.1 M | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 14.6 K | 13 K | |
| Ebit Per Revenue | (0.02) | (0.02) |
Currently Active Assets on Macroaxis
When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:Check out ViviCells International Piotroski F Score and ViviCells International Altman Z Score analysis. For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth (0.27) |
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.